Atlas Trials

Grass Pollen Allergy

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Grass Pollen Allergy

RecordFirmDate
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (NCT04502966)National Institute of Allergy and Infectious Diseases (NIAID)2020-11-05
Phase II Study of Grass Pollen Allergy Vaccine BM32 (NCT01538979)Biomay AG2012-03-01
Regulatory T-cells After Subcutaneous Immunotherapy (NCT01830673)Johann Wolfgang Goethe University Hospital2011-10-01
Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy (NCT01445002)Biomay AG2011-10-01
Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis (NCT01308021)BioTech Tools S.A.2010-12-01
A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment (NCT00773240)ALK-Abelló A/S2008-04-01
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture (NCT00264459)Allergopharma GmbH & Co. KG2003-02-01
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis (NCT00263601)Allergopharma GmbH & Co. KG2001-11-01

Track Grass Pollen Allergy automatically

Every clearance here is in the API, with alerts when new ones post.